Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-05-24FDA Approved: ERLOTINIB — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for Erlotinib (ERLOTINIB), enabling a generic version of the cancer drug to be…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC [Phase 2]
A Phase 2 trial evaluates L-TIL plus tislelizumab for PD-1 antibody–resistant advanced non-small cell lung cancer. The study is currently re…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer [NA]
This clinical trial update investigates the value of screening MRI brain in patients with stage IV non-small cell lung cancer (metastatic). …
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC [Phase 2]
A Phase 2 trial comparing neoadjuvant chemoimmunotherapy and immuno-consolidation after radical chemoradiotherapy for stage III potentially …
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen [Phase 2]
A Phase 2 study evaluating JTX-4014 alone and in combination with vopratelimab in biomarker-selected metastatic non-small cell lung cancer a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients
This clinical trial update examines whether circulating tumor cells can predict recurrence in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC [Phase 2]
A Phase 2 trial is evaluating cadonilimab plus chemotherapy as first-line treatment for PD-L1 negative non-small cell lung cancer, with pati…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer
An update on a clinical trial evaluating the clinical significance of circulating tumor cells in non-small cell lung cancer. The current sta…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ILB2109 in combination with toripalimab in patients with advanced solid malignancies, currently recrui…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC
This prospective, multicenter, non-interventional real-world study will characterize changes in molecular markers after three weeks of targe…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy. [Phase 2]
A prospective, single-arm Phase II trial evaluating Tafolecimab plus Sintilimab with chemotherapy in advanced or metastatic driver gene-nega…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: 99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC [EARLY_Phase 1]
An early Phase 1 study evaluated a radiolabeled anti-PD-L1 single-domain antibody (99mTc/68Ga-labeled) for imaging PD-L1 expression in non-s…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86) [Phase 3]
Phase 3 trial comparing subcutaneous pembrolizumab versus intravenous pembrolizumab with platinum doublet chemotherapy in metastatic non-sma…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Observational Study of Afatinib 30 mg Daily
Observational study evaluating afatinib 30 mg daily for non-small cell lung cancer with EGFR mutation; currently recruiting at National Univ…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer [NA]
A clinical trial update evaluating the ADL-Glittre Test to measure activities of daily living in patients with non-small cell lung cancer du…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC [Phase 2]
A Phase 2 trial is evaluating whether combining atezolizumab with carboplatin and nab-paclitaxel as neoadjuvant therapy can predict response…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with stereotactic ablative radiotherapy for metastatic colorectal cancer, non-…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation [Phase 2]
A Phase 2 trial updating on the combination of surufatinib and tislelizumab for advanced non-small cell lung cancer with neuroendocrine diff…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients [Phase 2]
A Phase II study of SSGJ-707 as first-line monotherapy for PD-L1 positive advanced non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS other · 2024-05-16Clinical Trial Update: Clinical Study of 18F-Alfatide Injection PET/CT [Phase 3]
A Phase 3 clinical trial update indicates an ongoing study of the PET/CT tracer 18F-Alfatide for non-small cell lung cancer, currently NOT_Y…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness
A completed clinical trial evaluated how patterns of tumor-draining lymph node metastasis relate to the effectiveness of neoadjuvant immunot…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy
Completed real-world study evaluating nivolumab in adults with advanced non-small cell lung cancer after prior chemotherapy.
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels [Phase 4]
A Phase 4 trial is comparing standard-dose alectinib to dose-adjusted dosing based on blood levels in ALK-positive non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study of GSK3901961 in previously treated synovial sarcoma, myxoid/round cell liposarcoma, and metastatic non-small cell lung canc…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery
A clinical trial update indicates Huaier Granules are being studied as adjuvant therapy after radical surgery in patients with non-small cel…